The weekly litigation news digest is live. Subscribe now

IP Verse

Merck Sharp & Dohme Llc V. Aurobindo Pharma Limited - 1:25-cv-00449

Merck Sharp & Dohme Llc V. Aurobindo Pharma Limited (Case No. 1:25-cv-00449), filed on Apr 11, 2025 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:25-cv-00449
Filing Date
Apr 11, 2025
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Merck Sharp & Dohme LLC -
Aurobindo Pharma Limited -

Patents Involved

There is a single patent involved in this case.

Application NumberPatent Number
-US7326708B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Apr 11, 2025Summons Issued as to Aurobindo Pharma Limited on 4/11/2025; Aurobindo Pharma USA, Inc. on 4/11/2025. (Attachments: # 1 Summons Issued)(oam) (Entered: 04/11/2025)PACER Document
Apr 11, 2025Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme LLC filed by Merck Sharp & Dohme LLC. (oam) (Entered: 04/11/2025)PACER Document
Apr 11, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (oam) (Entered: 04/11/2025)PACER Document
Apr 11, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/25/2025. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/25/2027. (oam) (Entered: 04/11/2025)PACER Document
Apr 11, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 04/11/2025)PACER Document
Apr 11, 2025COMPLAINT against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-4660319) - filed by Merck Sharp & Dohme LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(oam) (Entered: 04/11/2025)PACER Document